Search

Your search keyword '"Bianchi, Roberta"' showing total 522 results

Search Constraints

Start Over You searched for: Author "Bianchi, Roberta" Remove constraint Author: "Bianchi, Roberta"
522 results on '"Bianchi, Roberta"'

Search Results

Catalog

Books, media, physical & digital resources

5. Positive allosteric modulation of indoleamine 2,3- dioxygenase 1 restrains neuroinflammation

7. Aryl hydrocarbon receptor control of a disease tolerance defence pathway

9. Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice

10. Supplementary Method S1 from Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies

11. Supplementary Figure S2 from Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies

12. Supplementary Table S3 from Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies

14. Class IA PI3Ks regulate subcellular and functional dynamics of IDO1

16. A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells

17. Data from Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies

18. Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies

19. Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells

21. Video 1 from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

22. Video 3 from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

23. Supplemental figures from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

24. Supplemental methods from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

25. Supplemental data from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

26. Video 2 from CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

29. Tryptophan Catabolism in Nonobese Diabetic Mice

43. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy